-
The Cost of Managing Postpartum Hemorrhage: An Analysis by a Brazilian Health Insurer
Mar 10, 2025, 14:00 PM -
Cost and Clinical Characteristics of Acute Pancreatitis Hospitalizations Related and Unrelated to Hypertriglyceridemia
Mar 10, 2025, 14:00 PM -
Automated Extraction of Kaplan-Meier Survival Curves Using Generative Artificial Intelligence and Computer Vision
Mar 10, 2025, 14:00 PM -
Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs
Mar 10, 2025, 14:00 PM -
Increasing Costs of Hospitalizations for Multiple Myeloma in the United States: A Database Analysis on Aggregate Costs and Patient Subpopulations
Mar 10, 2025, 14:00 PM -
Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis
Mar 10, 2025, 14:00 PM -
Landscape of Patient-Reported Outcomes Measures (PROMs) in Oncology Trials: Key Insights Into Patient Voice and Value
Mar 10, 2025, 14:00 PM -
Economic and Health Care Resource Utilization (HCRU) Burden of Acute Myocardial Infarction (AMI) With or Without Systemic Inflammation in US Hospitals: A Real-World Study
Mar 10, 2025, 14:00 PM -
The Institute for Clinical and Economic Review and Joint Clinical Assessment: Insights for Manufacturers in an Evolving Health Technology Assessment Landscape
Mar 10, 2025, 14:00 PM -
Analysis of Antibody-Drug Conjugate Usage in Patients Undergoing Circulating Tumor DNA Testing
Mar 10, 2025, 14:00 PM -
Validity of Diagnostic Codes to Identify Metastatic Prostate Cancer in Medicare Claims Database
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Eladocagene Exuparvovec-tneq for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) and Comparison with Other Rare Disease One-Time Treatments in the United States
Mar 10, 2025, 14:00 PM -
Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis
Mar 10, 2025, 14:00 PM -
Redesigning the Care Process to Improve the Experience of Patients with Multiple Sclerosis Throughout the Patient Journey. EMpodera
Mar 10, 2025, 14:00 PM -
How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?
Mar 10, 2025, 14:00 PM -
The Impact of One-Day Surgery Performance Indicators on Hospital Capacities in Hungary
Mar 10, 2025, 14:00 PM -
Examining Health Behaviour of Inviduals Diagnosed With Polycystic Ovary Syndrome
Mar 10, 2025, 14:00 PM -
Dynamic Population Modelling Indicates a Flavored EVP Ban in the UK May Negatively Impact Population Health
Mar 10, 2025, 14:00 PM -
Estimation of Drug Cost Reductions by Introducing formularies for An Employment-based Health Insurance Plan : A Simulation Using “Wellness-Star☆” Health Insurance Claims Database
Mar 10, 2025, 14:00 PM -
Value of Personalized Refractive Procedure: A Survey of Perceived Clinical Outcomes, Practice Benefits, and Patient Satisfaction in China
Mar 10, 2025, 14:00 PM
